Protective effects of astragaloside IV against hypoxic pulmonary hypertension
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective effects of astragaloside IV against hypoxic pulmonary hypertension
Authors
Keywords
-
Journal
MedChemComm
Volume -, Issue -, Pages -
Publisher
Royal Society of Chemistry (RSC)
Online
2018-09-04
DOI
10.1039/c8md00341f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Research review on the pharmacological effects of astragaloside IV
- (2016) Lei Li et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation
- (2016) Wei-Na Yu et al. INFLAMMATION
- Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
- (2016) Ruiqin Huang et al. SAUDI PHARMACEUTICAL JOURNAL
- Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling
- (2015) Tong Chen et al. INFLAMMATION
- The Effects of Morin on Lipopolysaccharide-Induced Acute Lung Injury by Suppressing the Lung NLRP3 Inflammasome
- (2014) Zhang Tianzhu et al. INFLAMMATION
- Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway
- (2014) Xudong Cheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- FTY720 attenuates paraquat-induced lung injury in mice
- (2014) Jie Qian et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Outcome Prediction by Quantitative Right Ventricular Function Assessment in 575 Subjects Evaluated for Pulmonary Hypertension
- (2013) Nowell M. Fine et al. Circulation-Cardiovascular Imaging
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression
- (2013) Dingkun Gui et al. CYTOKINE
- κ-Opioid Receptor Stimulation Improves Endothelial Function in Hypoxic Pulmonary Hypertension
- (2013) Qi Wu et al. PLoS One
- Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
- (2012) Dingkun Gui et al. PLoS One
- Hypertension pulmonaire : de la physiopathologie moléculaire aux anomalies hémodynamiques
- (2012) S. Duong-Quy et al. REVUE DES MALADIES RESPIRATOIRES
- Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease
- (2011) Hibo Noureddine et al. CIRCULATION RESEARCH
- Determination of astragalin and astragaloside content in Radix Astragali using high-performance liquid chromatography coupled with pulsed amperometric detection
- (2011) Ha-Jeong Kwon et al. JOURNAL OF CHROMATOGRAPHY A
- Astragaloside IV Improves Homocysteine-Induced Acute Phase Endothelial Dysfunction via Antioxidation
- (2010) Li-Hong Qiu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
- (2009) Ari Chaouat et al. CHEST
- The Right Ventricle Under Pressure
- (2009) Harm J. Bogaard et al. CHEST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More